Sanofi Initiates Vaccine Tech Transfer, Facility Development in Vietnam

Sanofi and Vietnam Vaccine Company (VNVC) have initiated a vaccine production technology transfer project aimed at manufacturing certain Sanofi vaccines in Vietnam, enhancing local vaccine production capabilities. This collaboration, marked by a ceremony attended by Vietnamese President Luong Cuong and French President Emmanuel Macron, supports human resources training and quality management in vaccine research and production. VNVC is constructing a new vaccine production facility in Long An province with an initial investment of approximately $77 million, expected to produce around 100 million doses annually starting by the end of 2027. The partnership not only aims to improve Vietnam's vaccine access and autonomy in responding to health emergencies but also strengthens bilateral health relations and bilateral scientific and technological cooperation between Vietnam and France. This initiative aligns with the countries' upgraded Comprehensive Strategic Partnership, fostering collaboration in health, pharmaceuticals, and vaccine sectors. Overall, the project represents a significant step toward advancing Vietnam's biomedical capabilities and international cooperation in high-tech vaccine manufacturing.